Cytek Biosciences: Pay

Cytek Biosciences paid its 5 named executives $12.2M in total in FY2025 (Dec). CEO Wenbin Jiang, Ph.D. was paid $5.1M of that.

Pay$100 in the stock at the end of FY21 → $31
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Wenbin Jiang, Ph.D.Chief Executive Officer and President
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
William McCombeChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Valerie BarnettChief Legal Officer and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Ming Yan, Ph.D.Chief Technology Officer
FY2025 (Dec)
FY2024 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Philippe Busque, Ph.D.Senior Vice President, Global Sales and Services
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $8.1M. The CEO of Cytek Biosciences was paid $5.1M, 37% below the median.

  1. 1Twist Bioscience
  2. 2AtriCure
  3. 3Adaptive Biotechnologies
  4. 4Standard Biotools
  5. 5Veracyte
  6. 610x Genomics
  7. 7Angiodynamics
  8. 8Cytek Biosciences
  9. 9Pacific Biosciences Of California
  10. 10Axonics, Inc.Not disclosed
  11. 11BioLife Solutions, Inc.Not disclosed
  12. 12Codexis, Inc.Not disclosed
  13. 13Harvard Bioscience, Inc.Not disclosed
  14. 14Mesa Laboratories Inc /Co/Not disclosed
  15. 15Nevro Corp.Not disclosed
  16. 16QuanterixNot disclosed
  17. 17Surmodics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.